Addition ofepidermal growth factor (EGF) to quiescent cultured cells was found to stimulate the activity of glycogen synthase (UDPglucose:glycogen 4-a-D-glucosyltransferase, EC 2.4.1.11), an enzyme subjected to regulation by covalent modification. In Swiss mouse 3T3 cells, the activation by EGF paralleled the effect seen with insulin; the time course and dose-response curves of the two polypeptide factors were similar. Stimulation of enzyme activity ratio [(activity in the absence of glucose 6-phosphate)/(activity in the presence of glucose 6-phosphate)] was maximal after 20-30 min of incubation. Both factors caused a maximal stimulation of 2.5-fold in synthase activity ratio at w10 nM, and the half-maximal effect was observed at 0.1-1 nM. Insulin and EGF exhibited partial additivity in effecting this enzyme activation. In contrast, human A431 cells showed no response to insulin. Although quantitatively different, the EGF effect in the latter cells was time dependent, reaching a maximum at 90 min, and dose dependent, with a maximal stimulation of 4-fold in synthase activity ratio at 10 nM. Half-maximal effect was observed at 0.3 nM EGF. Direct quantitation of allosteric effectors (glucose 6-phosphate, adenine nucleotides, and Pi) present in the enzyme assay mixtures indicated that the observed activation was not simply a consequence of changes in metabolite concentrations. These results suggest that EGF may be important in regulating glycogen synthesis through phosphorylation/dephosphorylation mechanisms.
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Epidermal growth factor (EGF) stimulates the growth of a variety of cell types in culture (for review, see ref. 1) . Its known metabolic effects include stimulation of ion fluxes (2) , glucose transport (3) , glycolysis (4) , and protein and DNA synthesis (1, (5) (6) (7) (8) . Prevailing evidence indicates that the EGF receptor has intrinsic protein tyrosine kinase activity (for review, see ref. 9 ). Upon addition of EGF, this activity is stimulated severalfold, and there is a general increase in the abundance of total intracellular protein phosphotyrosine (5, (9) (10) (11) (12) . Specific serine phosphorylation of some proteins is also increased, as in the case of the 40S ribosomal protein S6 (6, 7, 13) .
Glycogen synthase (UDPglucose:glycogen 4-a-D-glucosyltransferase, EC 2.4.1.11), a key enzyme involved in the control of glycogen metabolism, is known to be regulated by hormones that act to control its phosphorylation state (14) (15) (16) (17) (18) (19) (20) (21) (22) . To date, there are at least seven known sites of phosphorylation on the enzyme; all are on serine (22) or threonine (23) residues. Insulin causes an activation of glycogen synthase with a concomitant decrease in the phosphate content of the enzyme (14, 15, (17) (18) (19) (20) (21) (22) . The activated or less phosphorylated form of the enzyme can be measured in the absence of added glucose 6-phosphate (Glc-6-P), an allosteric activator, while the total amount of the synthase can be measured in the presence of saturating concentrations ofGlc-6-P. The enzyme activity ratio [(activity in the absence of Glc-6-P)/(activity in the presence of Glc-6-P)] thus provides a useful index for following changes in the state of activation of the enzyme.
Considering that EGF is known to have certain metabolic effects similar to those of insulin (1-8), we decided to investigate its effect on glycogen synthase activity. In this paper, we report that EGF stimulates this enzyme activity in quiescent cultures of two mammalian cell lines.
EXPERIMENTAL PROCEDURES
Materials. EGF and insulin were purchased from Collaborative Research (Waltham, MA). Dulbecco's modified Eagle's medium (DME medium) and fetal bovine serum were obtained from GIBCO. UDP-[U-14C]glucose was purchased from New England Nuclear. UPD glucose and Glc-6-P were purchased from Sigma. Oyster glycogen was obtained from Calbiochem and purified before use (24) . Glc-6-P dehydrogenase from Leucoi, ostoc mesenteroides was from Boehringer Mannheim. Bacterial Luciferase from Vibrio fischeri was from Sigma. All other chemicals were of reagent grade.
Cell Cultures. Swiss mouse 3T3 cells and A431 human epidermoid carcinoma cells were grown to confluence on 150-mm plastic dishes in a humidified atmosphere of 5% C02/95% air at 370C. The growth medium was made up with DME medium containing 5.6 mM glucose, and it was supplemented with 10% fetal bovine serum/100 units ofpenicillin per ml/100 ,ug of streptomycin per ml.
Cell Incubation and Preparation of Extracts. Confluent cultures were shifted to DME medium containing 0.1% fetal bovine serum on the day before the incubation experiments. hr, the cells were rinsed once with fresh DME medium (no added serum) and incubated with 14C]glucose (0.7-1.2 uCi/4&mol; 1 Ci = 37 GBq), with or without 20 mM Glc-6-P. After 20 min at 306C, a 75-1.l aliquot of the reaction mixture was spotted on filter paper (Whatman 31ET). The paper squares were washed in cold 66% (vol/vol) ethanol, dried, and the radioactivity incorporated was measured by liquid scintillation counting. Units of activity are expressed in terms of nanomoles of UDP glucose incorporated into glycogen per min per mg of cell supernatant protein. The glycogen synthase activity ratio is the activity in the absence of Glc-6-P divided by the activity in the presence of 10 mM Glc-6-P. The apparent activation constant (Ka) of Glc-6-P in the cell extracts was determined over the range of 0.4 FM to 10 mM Glc-6-P.
Metabolite Determinations. Metabolites were measured in neutralized perchloric acid extracts prepared as follows. Cell extracts were treated with perchloric acid at a final concentration of 0.6 M. After protein removal by centrifugation, the supernatants were adjusted to pH 5-6 with 2 vol of 0.5 M tri-n-octylamine prepared in chloroform. Glc-6-P was quantitated enzymatically by coupling the Glc-6-P dehydrogenase reaction to the bacterial Luciferase reaction (26, 27) . ATP, ADP, and AMP were measured by HPLC (28) . Pi was measured enzymatically according to Cornell et al. (29) .
Protein Determination. Pellets obtained from cell extracts treated with perchloric acid were solubilized in 0.8 M NaOH. Protein content was then determined by the method of Lowry et al. (30) as modified by Peterson (31) . Bovine serum albumin was used as a standard.
RESULTS
Glycogen synthase activity was examined in two different mammalian cell lines-namely, Swiss mouse 3T3 cells and A431 human epidermoid carcinoma cells. The 3T3 cells have both insulin and EGF receptors, and the growth-promoting activity of the two polypeptide factors in these cells has been well documented (1) (2) (3) (4) (5) (6) (7) (8) 32) . The A431 cells have an unusually high density of EGF receptors (33, 34) . Proliferation of these cells is known to be stimulated only by low (picomolar) but not high (nanomolar) concentrations of EGF (35) (36) (37) . It has not been reported whether A431 cells have insulin receptors.
Effects of EGF and Insulin on Glycogen Synthase Activity in 3T3 Cells. When grown to confluence in 10% serum/DME medium, 3T3 cells exhibited a basal synthase activity ratio ranging between 0.10 and 0.19. After 20-24 hr in 0.1%o serum/DME medium, the basal ratio remained approximately the same, at 0.08-0.16. Total enzyme activity assayed in the presence of 10 mM Glc-6-P (i.e., sum activity of Glc-6-P-dependent and Glc-6-P-independent forms) was 3.6-6.2 nmol min-l mg-1 of extract protein. This activity did not vary with different treatments; the values were similar in all extracts at all time points, with or without added polypeptide factors. However, enzyme activities measured in the absence of added Glc-6-P (i.e., Glc-6-P-independent activity) varied depending on treatment and, in turn, led to changes in the calculated activity ratio. Exposure of serum-deprived cells to fresh DME medium alone caused a slight increase in the activity ratio within 10 min. The stimulatory effects of EGF and insulin were maximal at 20-30 min and then gradually declined; the effect was no longer evident after 90 min (Fig. 1 ). This enzyme activation was concentration dependent, as shown in Fig. 2 . Both polypeptide factors caused a maximal stimulation of 2.5-fold in synthase activity ratio at *10 nM. Half-maximal stimulation was observed at 0.1-1 nM. When both factors were added together in the incubations, an even higher stimulation of synthase activity could be demonstrated. As shown in Table 1 0.12-0.17. Since this was slightly less than the increase of 0.23 caused by EGF alone, the effects of these two factors on glycogen synthase activity were only partially additive. However, even when both polypeptide factors were present at their maximal stimulatory concentrations, the highest assayed activity ratio was only 0.55 (Table 1) , while the fully activated enzyme may attain a ratio of almost 1.
Effects of EGF on Glycogen Synthase Activity in A431 Cells.
Incubation in 0.1% serum/DME medium for 20-24 hr caused an =30%o decrease in the synthase activity ratio in A431 cells (from 0.24-0.33 to 0.16-0.23), due solely to a decrease in enzyme activity measured in the absence of Glc-6-P. In control cells incubated with DME medium only, total enzyme activities assayed in the ?resence of 10 mM Glc-6-P ranged from 3.4 to 5.6 nmol'min -mg1 ofextract protein and did not vary significantly over a 240-min period. The calculated basal synthase activity ratio remained fairly constant for the first 120 min but was decreased by 240 min. With the addition of 16.4 nM EGF, the activity in the presence ofGlc-6-P declined slightly with time (from 4.7 to 3.1 nmol min-1 mg-1 by 240 min), while activity in the absence of Glc-6-P progressively increased (from 0.8 to a maximum of 2.5 nmol'min-l mg-1 by 90 min). The effect of EGF on the activity ratio was thus caused by a combination of both a decrease in total enzyme activity and an increase in Glc-6-P-independent activity, although primarily by the latter. This EGF effect was first apparent between 40 and 60 min, was maximal at 90 min, and remained elevated through 240 min (Fig. 3) . The dose dependency of this response is shown in Fig. 4 . A maximal stimulation of 4-fold increase in synthase activity ratio was observed at 10 mM EGF and half-maximal stimulation was observed at 0.3 nM. In contrast, the glycogen synthase activity ratio was not altered by insulin when measurements were made over a period of 120 min and at insulin concentrations of 8.3 nM (50 ng/ml) and 167 nM (1000 ng/ml) (data not shown).
Metabolite Levels in Cell Extracts. The question arose as to whether low molecular weight compounds carried over into the enzyme assay reaction mixtures might contribute to the observed increase in glycogen synthase activity ratio. Glc-6-P is a potent allosteric activator for this enzyme, while the adenine nucleotides and Pi are known to be inhibitors (15) (16) (17) 38) , so it was important to determine whether these allosteric effectors might be present in the assays at concentrations that would affect the enzyme activity measured in the absence of externally added Glc-6-P (i.e., the activity in the absence of Glc-6-P). The measured total activity (i.e., the activity in the presence of Glc-6-P) would not be affected, because 10 mM Glc-6-P is known to overcome the effects of inhibitors. We addressed this question by directly quantitating metabolite concentrations in the same cell extracts used for enzyme activity measurements. In extracts prepared from the two cell types, Glc-6-P concentrations were found to be between 1. of this compound for the purified active form of glycogen synthase ranged from 2 to 200 AM (15) (16) (17) , depending on tissue source of the enzyme preparations as well as on assay conditions. Since the Ka of glycogen synthase for Glc-6-P from these cultured cells was not known, we opted to determine the apparent activation constant of Glc-6-P in the cell extracts. In Sephadex G-25 filtrates, we found the apparent Ka for Glc-6-P to be 220 MM in the control 3T3 extract and 40-45 AM in the EGF-and insulin-stimulated extracts. In A431 cells, the Ka was found to be 70 AM in the control extract and 22 AM in the EGF-stimulated cell extract. Considering a 1:2 dilution of cell extracts when introduced into enzyme assays, the endogenous Glc-6-P concentrations in our assays were thus lower than the lowest measured apparent activation constant by at least a factor of 7. Moreover, there was no apparent linear correlation between variation in synthase activity ratio and variation in Glc-6-P concentrations in extracts of either cell type (y2 = 0.12; n = 74). ATP, ADP, and AMP concentrations in extracts were in the range of 0.6-2, 2-6, and 1-3 MM, respectively. Pi concentrations were estimated to be <50 AM. These values were all substantially lower than the millimolar inhibition constants (Kg) reported for glycogen synthase (15) (16) (17) 38) . Based on these findings, we conclude that the above allosteric effectors do not play a significant role in the observed activation of glycogen synthase by EGF and insulin.
DISCUSSION
Glycogen synthase is the rate-limiting enzyme in the pathway of glycogen synthesis, and hormonal regulation of its activity in mammalian tissues is mediated primarily through phosphorylation/dephosphorylation mechanisms (14) (15) (16) (17) (18) (19) (20) (21) (22) . The less active Glc-6-P-dependent form can be converted to the more active Glc-6-P-independent form through dephosphorylation reactions (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) . Since the enzyme is phosphorylated on multiple sites, it is as yet not clear how many kinetically distinct forms of synthase could be defined.
Nevertheless, the conventionally used synthase activity ratio (activity in the absence of Glc-6-P/activity in the presence of Glc-6-P) still provides a useful index of changes in the In adipose tissue and skeletal muscle (19) (20) (21) (22) , it has been well established that insulin regulates glycogen synthase in a glucose-dependent pathway (possibly through increased glucose transport) and a glucose-independent pathway (possibly through phosphorylation/dephosphorylation). In a manner similar to insulin, EGF is known to increase glucose transport (3) as well as glycolytic flux (4) . Since (9, 39) . A comparative study conducted in our laboratory (39) using proteins and peptide substrates indicated that the EGF-and insulin-stimulated tyrosine kinases from human placenta have very similar specificities, which might in turn be related to the similar cellular responses elicited by the two polypeptide factors (1) (2) (3) (4) (5) (6) (7) (8) . The present study indicated that these two factors also have similar effects on glycogen synthase activation. Since this activity change has been associated with a decrease in the phosphate content of the synthase molecule, possible mechanisms might involve an activation of phosphatase(s), an inhibition of kinase(s), or both (14, 15, (17) (18) (19) (20) (21) (22) 
